Nexlizet Dosage
Generic name: BEMPEDOIC ACID 180mg, EZETIMIBE 10mg
Dosage form: tablet, film coated
Drug class: Antihyperlipidemic combinations
Medically reviewed by Drugs.com. Last updated on Jun 5, 2024.
Recommended Dosage and Administration
- The recommended dosage of NEXLIZET is one tablet orally once daily. One tablet of NEXLIZET contains 180 mg of bempedoic acid and 10 mg of ezetimibe.
- Swallow the tablet whole. NEXLIZET can be taken with or without food.
- If a dose is missed, take the missed dose as soon as possible. Do not double the next dose.
- After initiation of NEXLIZET, analyze lipid levels within 8 to 12 weeks.
Frequently asked questions
More about Nexlizet (bempedoic acid/ezetimibe)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (14)
- Drug images
- Side effects
- Patient tips
- During pregnancy
- FDA approval history
- Drug class: antihyperlipidemic combinations
- En español
Patient resources
Professional resources
Related treatment guides
See also:
Lipitor
Lipitor is used to treat high cholesterol. Learn about side effects, interactions and indications.
Crestor
Crestor (rosuvastatin) is used to treat high cholesterol and high triglycerides in the blood ...
Ozempic
Learn about Ozempic (semaglutide) for type 2 diabetes treatment, weight management, cardiovascular ...
Repatha
Repatha is used to lower high cholesterol alongside dietary changes and to reduce the risk of major ...
Zetia
Zetia (ezetimibe) is used to treat high cholesterol. Includes Zetia side effects, interactions and ...
Zocor
Zocor (simvastatin) reduces low-density lipoprotein cholesterol and total cholesterol in the blood ...
Lovastatin
Lovastatin is used for high cholesterol, high cholesterol, familial heterozygous ...
Pravastatin
Pravastatin (Pravachol) is a statin medicine used to lower cholesterol and triglycerides in the ...
Simvastatin
Simvastatin (Zocor) is a cholesterol-lowering medication that blocks the production of cholesterol ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
